J. Perry Hall
Pfizer (United States)(US)
Publications by Year
Research Areas
NF-κB Signaling Pathways, Immune Response and Inflammation, Melanoma and MAPK Pathways, Cytokine Signaling Pathways and Interactions, interferon and immune responses
Most-Cited Works
- → Innate Immune Recognition of an AT-Rich Stem-Loop DNA Motif in the Plasmodium falciparum Genome(2011)257 cited
- → An NLRP3-specific inflammasome inhibitor attenuates crystal-induced kidney fibrosis in mice(2016)189 cited
- → Efficacy and Pharmacology of the NLRP3 Inflammasome Inhibitor CP-456,773 (CRID3) in Murine Models of Dermal and Pulmonary Inflammation(2016)175 cited
- → SMK1, a developmentally regulated MAP kinase, is required for spore wall assembly in Saccharomyces cerevisiae.(1994)161 cited
- → Discovery of PF-06928215 as a high affinity inhibitor of cGAS enabled by a novel fluorescence polarization assay(2017)159 cited
- → The Osmoregulatory Pathway Represses Mating Pathway Activity in Saccharomyces cerevisiae : Isolation of a FUS3 Mutant That Is Insensitive to the Repression Mechanism(1996)97 cited
- → JNK initiates a cytokine cascade that causes Pax2 expression and closure of the optic fissure(2003)89 cited
- → Multivalency in the Assembly of Intrinsically Disordered Dynein Intermediate Chain(2009)77 cited
- → Pharmacologic Inhibition of Tpl2 Blocks Inflammatory Responses in Primary Human Monocytes, Synoviocytes, and Blood(2007)76 cited
- → Mice lacking Tbk1 activity exhibit immune cell infiltrates in multiple tissues and increased susceptibility to LPS-induced lethality(2010)74 cited